10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Wednesday, August 27, 2008

Natco Pharma:-Cheapest bet in the pharma sector

ScripScan:Natco Pharma Ltd
Traded on:Nse-Bse

Story:Natco Pharma is engaged in manufacturing and marketing bulk drugs,formulations,contract manufacturing and retail pharmacy.Bulk drugs in its portfolio include Citalapram, Serfroline(anti-depressant),Sumatriptan succinate (anti-migraine),imatinib mesylate,gettinib and zoladronic acid (anti-cancer).In the domestic market it has significant presence in oncology (anti-cancer) formulations segment.Formulations include Veenot (blood cancer), Bortenat, Gettinat (lung cancer), Temonat (brain cancer),Zaldon(bone cancer),tetronat (breast cancer).Exports contributes a significant part of its turnover with almost entire bulk drug production is exported mainly to regulated markets of USA and Europe.Formulation sales are mainly in the domestic market.The company is engaged in contract manufacturing of formulations for domestic companies like Novartis, Glaxo,Ranbaxy, Sun Pharma and Dr. Reddy's Lab.The company is persuing strategy to de-risk the cost of filing ANDA. It has signed an agreement with Akorn under the terms of which it will supply API while Akorn will bear the cost of ANDA.Natco is planning big thrust in retail stores due to: it will help company to push its own formulations in U.S. Market, profit margin in retail stores is around 10%,acquisition cost for a retail store with revenues of USD 15-20 mn works out to hardly USD 2.75 -3.00mn.Company may acquire a total of 6-8 retail stores soon which ultimately will be merged with Natco.Subsequently, to unlock value for Natco, stake holders, retail division may come out with IPO.Company has a land bank of approx.350 acres around 40 Km. away from Hyderabad city (near New International Airport).Current market value of this land is approx. Rs. 320 crs. which works out to Rs. 110/- per share.Company is likely to set up an SEZ on this land which will provide huge revenues from 08-09 onwards.It may be noted that acquisition cost of this land is perhaps less than 20 crs.Stock is trading at 4.6 times its FY09E Earnings which is one of the lowest in pharma sector.CMP is less than value per share of its land bank which means investors are getting Natco for free (its pharma business). Once company launches SEZ, it will be a BIG Trigger for this scrip.Moreover, market value of this land bank can still rise significantly once New International Airport becomes operational.Natco Pharma is highly undervalued, least risky and extremely attractive buy.Investors can easily appreciate their money by 60-100% in next 12-15 months by buying Natco Pharma.

I can be reached

No comments:

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner